Basic good manufacturing practices (GMP), special conditions and inspection processes in the covid19 (SARS-CoV-2) pandemic

Basit Öğe Kaydı
dc.authoridAbdullah Levent Alparslan / 0000-0003-0113-6850en_US
dc.authorscopusidAbdullah Levent Alparslan / 57970361500en_US
dc.authorwosidAbdullah Levent Alparslan / AAP-3253-2020en_US
dc.contributor.authorAlparslan, Abdullah Levent
dc.date.accessioned2022-12-19T06:33:12Z
dc.date.available2022-12-19T06:33:12Z
dc.date.issued2022en_US
dc.departmentİstinye Üniversitesi, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümüen_US
dc.description.abstractThe COVID-19 pandemic has severely impacted the world economy, businesses and global health. Exceptional situations are evident in the food, cosmetics and pharmaceutical production in the supply chain, where many businesses have been shut down completely following government restrictions. In the pandemic process, it has become much more important to ensure hygienic products and employee safety and to deliver quality and healthy products to the consumer. In extraordinary conditions, it is necessary to provide additional contributions to the principles of good manufacturing practices. With the additional measures to be taken during the epidemic period, a healthy and safe operation can be brought to production. In addition, the assurance system can continue to function despite restrictions and failing audits. In addition to the updated guides, the development of roadmaps specific to the epidemic period for production may provide the advantage of being ready for problems. © 2022 Marmara University Press.en_US
dc.identifier.citationALPARSLAN, A. L. (2022). Basic good manufacturing practices (GMP), special conditions and inspection processes in the Covid19 (SARS-CoV-2) pandemic. Journal of Research in Pharmacy, 26(6).en_US
dc.identifier.doi10.29228/jrp.247en_US
dc.identifier.isbn26306344
dc.identifier.scopus2-s2.0-85142171048en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.trdizinid1175939en_US
dc.identifier.urihttp://dx.doi.org/10.29228/jrp.247
dc.identifier.urihttps://hdl.handle.net/20.500.12713/3602
dc.identifier.wosWOS:000893010600003en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.institutionauthorAlparslan, Abdullah Levent
dc.language.isoenen_US
dc.publisherMarmara Universityen_US
dc.relation.ispartofJournal of Research in Pharmacyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCovid19en_US
dc.subjectGMPen_US
dc.subjectGDPen_US
dc.subjectProductionen_US
dc.subjectGuideen_US
dc.subjectİnspecionen_US
dc.subjectPandemicen_US
dc.subjectSARS-CoV-2en_US
dc.titleBasic good manufacturing practices (GMP), special conditions and inspection processes in the covid19 (SARS-CoV-2) pandemicen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Dr.-Ecz.-Levent-ALPARSLAN.pdf
Boyut:
527.82 KB
Biçim:
Adobe Portable Document Format
Açıklama:
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Eczacılık Teknolojisi Bölümü Bildiri Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu